NCT07732686Not yet recruiting
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Breath Volatile Organic Compounds (VOC) Analysis Using Proton Transfer Reaction Mass Spectrometry (PTR-MS)
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
The purpose of this clinical trial is to evaluate whether volatile organic compound (VOC) signatures detected in the breath of patients with cancer can serve as a potential screening tool for the early detection of cancer.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 23 Jul 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- University of Oklahoma
- Diseases
- Head and neck cancer, Bladder cancer, Lung cancer, Pancreatic cancer, Colorectal cancer, Liver and biliary tract cancer, Ovarian cancer
- NCT number
- NCT07732686
What you commit to
- Study type: Observational
- Planned participants: 2000
- From 1 Oct 2026 to the primary completion date, 31 Oct 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Cancer patients who are on active treatment for cancer or have received cancer treatment within one month
Other illness
- Active respiratory infection symptoms
Age
- Under the age of 18.
Other
- Anticipated inability to complete breath sampling procedure.
- Unable to provide informed consent.
- Pregnant women
- Recent use of antibiotics
- Difficulty in performing coached exhalation
- Individuals who are unable to follow the instructions
Who the study is looking for
- Age ≥ 18 at the time of consent. Male and female patients to be tested.
- Capable of understanding written and/or spoken English language.
- Able to provide informed consent.
- Cancer of any type.
- Newly diagnosed cancer and untreated or established diagnosis of cancer. For established cancer patients, no active anti-cancer treatment for more than one month (reasons for no treatment are such as relapse, progression of cancer, refractory, or intolerance to treatment etc.)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| OU Health Stephenson Cancer Center Coordinator of this site? Confirm its status | Oklahoma City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.